Best�s Market Segment Report: AM Best Maintains Stable Outlook on Taiwan�s Non-Life Insurance Market

3 years ago

HONG KONG--(BUSINESS WIRE)--#insurance--AM Best is maintaining a stable market segment outlook on Taiwan�s non-life insurance segment, citing robust underwriting and…

VeriSilicon Image Signal Processor IP Achieved ISO 26262 Automotive Functional Safety Certification

3 years ago

The awarded certificate accelerates VeriSilicon�s strategic deployment in autonomous driving and the automotive segment in general SHANGHAI--(BUSINESS WIRE)--#AI--VeriSilicon (688521.SH), a…

DHL Supply Chain is entrusted by GE Healthcare Japan with logistics operations to optimize healthcare service parts logistics

3 years ago

DHL Supply Chain opens five new logistics centers in Japan to meet the increasing demand of Service Parts for healthcare…

Hagens Berman: Sun and Ranbaxy Facing January Trial as Federal Judge Denies Summary Judgment in Generic Drug Overpricing Lawsuit

3 years ago

Attorneys will take antitrust case to trial in January 2022 BOSTON--(BUSINESS WIRE)--#antitrust--Yesterday, a federal judge denied all motions for summary…

EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)

3 years ago

EBR Systems� WiSE� CRT System is world�s first and only wireless endocardial (inside the heart) left ventricle pacing system for…

BeiGene Announces Approval of BRUKINSA (zanubrutinib) in the European Union for Treatment of Adults with Waldenstr�m�s Macroglobulinemia

3 years ago

EU approval follows recent approvals for BRUKINSA including U.S., China, Brazil, and Canada The approval is based on Phase 3…

Republic of Palau Partners with Ripple to Develop Digital Currency Strategy

3 years ago

Palau to explore using the XRP Ledger to create world�s first government-issued national stablecoin SAN FRANCISCO & NGERULMUD, Palau--(BUSINESS WIRE)--Ripple,…

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial in China of GlycoMimetics� Uproleselan for the Treatment of AML

3 years ago

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Apollomics has dosed the first patient in China in a Phase…

ALSP Orchid Acquisition Corporation I Announces $172.5 Million Initial Public Offering

3 years ago

SEATTLE--(BUSINESS WIRE)--ALSP Orchid Acquisition Corporation I (NASDAQ: ALORU) (the �Company� or �ALSP Orchid�) today announced that it has closed its…